glp-1 legal team in louisiana law office semaglutide digestive blockage lawsuit in louisiana glp-1 digestive blockage law office in louisiana Ozempic Lawsuit [May 2026 Update]-150cent-mvanhaasteren.nl Weight Loss Injections | Weight

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

A federal judge in Texas is allowing Eli Lilly &amp

Through craving control and reduced appetite, GLP-1 Boost provides an alternative to injections while still helping you reach your weight loss goals.

Recovery Centers of Americas Chief Medical Officer Jason Kirby, DO, MBA, DFASAM, recently authored an article featured in Drug Discovery Online.

PharmEasy explains common GLP-1 side effects and practical tips to manage them